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Modern Concepts in Brain Tumour
Therapy: Laboratory and Clinical In-
vestigations, National Cancer Institute
Monograph 46. (1977) U.S. Department
of Health Education and Welfare. 250 pp.
This volume consists of papers presented
at a conference on brain tumours held in 1976,
and it is of considerable interest to all those
many scientific and medical disciplines in-
terested in the problems of these tumours.
In the first section the development of
animal tumour models by exposure to differ-
ent types of oncoviruses and chemical
carcinogens which will produce histologically
similar tumours to those occurring in man,
and their use as models to study the effect of
anti-tumour agents, both radiation and
chemotherapy is described, as well as funda-
mental research into pharmacokinetics,
tumour cell kinetics, immunology and the
blood-brain barrier. All are features of great
importance in planning for successful applica-
tion of chemotherapy to brain tumours, but
warnings are also given that information
from these animal models may not be trans-
ferable to man, e.g. procarbazine produced no
response in animals whereas it has an anti-
tumour effect in man.
The next section looks at the pathology of
the brain tumours, and one paper compares
that of the animal tumour models to that
found in man. The difficulties of pathological
classification in such a protean group of
tumours is stressed.
There is a good paper on the radiation
damage to normal monkey brain with differ-
ent single and fractionated doses. With mega-
voltage, 1000 rad as a single dose and 4000
radin4 weeks produced nodamage, butabove
these doses considerable damage occurred.
The changes in blood vessels and brain tissue
following necrosis are described. Some of
these changes are also described in the
autopsies of patients treated for brain
tumours.
The next section discusses the diagnosis of
brain tumours, with particular reference to
isotope scanning, and the newer technique of
computed tomography with and without
enhancement; both for diagnosis and con-
tinued evaluation after treatment. Other
evaluation methods included the CSF meas-
urement of desmosterol and polyamines.
The antigen-like compounds astrocytin and
malignin are also described in this section.
The next section relates to the various
treatment modalities used for brain tumours
-the place of surgery, steroids, radiotherapy
and chemotherapy, and possible use ofhyper-
baric 02 for increasing the radiation effect.
The final section discusses prognostic
factors, the criteria forresponse, andthe prob-
lems relating to evaluation and diagnosis of
definite tumour recurrence.
Finally, the Brain Tumour Study Group's
various trials are described and, in more
detail, the radiation therapy time/dose frac-
tion trial for metastatic brain tumours.
This collection of papers brings together a
good deal of useful information about brain
tumours, and at present most of this has not
been overtaken by later developments. A
useful collection of papers on this subject.
D. PEARSON
Breast Cancer-II. Advances in Research
and Treatment-Experimental Bi-
ology. Ed. W. L. McGUIRE (1978) New
York and London: Plenum Medical Book
Company. 407 pp. £22.05.
This is the second volume in the only
series devoted to breast cancer. The first
dealt exclusively with therapy of the disease;
this one covers aspects of experimental
biology fundamental to our understanding of
problems concerned with breast cancer, viz.
aetiology, mechanisms of hormone action,
cell kinetics, experimental therapy and
biological markers. In addition, the volume
contains a significant contribution from that
elite corps, the molecular biologists, who have
lately begun to investigate the mechanisms
of hormone action in breast cancer.
The outcome is a comprehensive synthesis
of concurrent research along several frontiers
ofknowledge. The standard of the individual
contributions is not diminished by the multi-
disciplinary nature of the volume which is
demanded by so complex a subject. In these
days, when research projects in breast cancer,174 BOOK REVIEWS
as in most other diseases, are so highly
orientated, the availability of a text which
traverses the boundaries of the various
disciplines is to be welcomed. The volume has
the additional advantage of extensive biblio-
graphies after each article. It is thus an
excellent work of reference, as well as an up-
to-date account of the status of breast cancer
research.
M. MOORE
Opportunistic Infection in Cancer
Patients. J. AUBERTIN, B. HOERNI, J. Y.
LACUT & M. DURAND (1978). U.S.A.:
Masson Publishing. 197 Pp. £15.80.
With advances in cancer treatments, par-
ticularly cytotoxic combinations, the prog-
nosis in several tumours has improved con-
siderably over the past decade. Not un-
expectedly, this has in some instances led to
increased toxicity, particularly in opportunis-
tic infections. These are readily amenable to
appropriate treatment, and can be resolved
satisfactorily if the clinician is alert to the
problem and instigates the correct therapy.
This book therefore comes at an opportune
time and presents an up-to-date review of
important aspects in the management of
infection in the patient with cancer.
The first section deals with general topics,
in particular those factors that predispose to
infection, and adequate coverage is given to
aetiology and problems concerned with
diagnosis. The second section deals with
clinical and diagnostic aspects, and detailed
coverage is given to the important opportun-
istic infections due to fungi-and parasites. The
final section is devoted to treatment, and
adequate discussion is given here to current
antibiotic policy. I think, however, that it
would have given added credence to the book
ifmore space had been devoted to supportive
care. It is, however, a book that is to be
recommended to all those concerned in the
clinical management of cancer patients. At
£15.80 it is probably beyond the reach of
junior staff, but should be present in all
relevant libraries.
P. M. WILKINSON
Endometrial Cancer. Eds. M. G. BRUSH,
R. J. B. KING & R. W. TAYLOR (1978).
London: Bailliere Tindall. 459 pp. £16.50.
This is not a text book, but the collected
papers presented at the Second International
Conference on Endometrial Cancer in May
1977. Forty-five papers gathered into 8
sections are republished without any of the
attendant discussions or editorial summaries
that one might have expected. The papers
range from general reviews to individual
scientific studies of widely varying size and
complexity. The general introductions and
discussions within the papers contain an
extensive amount of overlapping information
which, while complete within the context of
the paper, is tedious if papers are read
sequentially. The 8 sections cover the whole
range ofthe relatively neglected field ofendo-
metrial carcinoma, with those on epidemi-
ology, long-term oestrogen therapy, clinical
treatment and experimental endocrinology
occupying the bulk of the book.
Looking at the individual papers, in the
first section there is an excellent review
by Mack of the validity of the different
arguments surrounding oestrogen therapy
and the possible changing incidence of the
disease.
The second section, on the relationship of
oestrogens and carcinoma, opens with a
balanced review ofthe problem by Lauritzen.
His rules for long-term oestrogen therapy are
impressive for their simplicity and common
sense. The section then strays away from
malignant disease to good papers by Sturdee
and Whitehead, detailing the uterine mucosal
response to different oestrogen therapies. The
unpredictability ofthis response and the need
for sequential analysis of endometrial tissue
emerges clearly.
Ober's Recent Ideas on the Pathology of
Endometrial Carcinoma opens the pathology
section. The clarity of style produces an
authoritative view ofthis difficult field, which
must not be missed by any clinically orien-
tated reader.
The long section on Clinical Treatment in-
cludes papers discussing the extent ofprimary
surgery, the relative values of pre- and post-
operative radiotherapy, adjuvant progesto-
gens in early disease and progestogens in late
and recurrent disease. All the results pre-
sented come from clinical studies which seek
to answer questions that can only be
answered by randomized clinical trials. The
points of view are well presented and
cogently argued, but their long-term value is
very limited. In later papers Kohorn does